Vivaldi Biosciences
Vivaldi Biosciences is developing a more effective seasonal flu vaccine addressing the unmet needs of adults age 50 and older.
Business Model:
Revenue: $15M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Vivaldi Biosciences Information
Geographic Data
Address: 462 1st Ave
City: New York
State: NY
Zip: 10016
Country: US
Financial Info
Stage:
series unknown
Raised Last:
$2M
Raised Total:$23M
Social
Metrics
6,893,521Website Global Rank
741Website Monthly Traffic
Twitter Followers
Description
Vivaldi Biosciences is developing a more effective seasonal flu vaccine addressing the unmet needs of adults age 50 and older.
Contact Phone:
+16463816680
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2009 | Series A | 2 | $23M |
Bay City Capital NGN Capital Bay City Capital NGN Capital |
7/2010 | Venture Round | $2M | 5/2007 | Series A | 1 | $2M |
Bay City Capital Bay City Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
